[10] We found, however, that CD10 expression predicted a worse outcome in more aggressive subsets of MCL patients, such as those with Ki67 > 60%, blastoid/pleomorphic morphology, or a high MIPI score. This evidence concerns the gene MME and mantle cell lymphoma.